Literature DB >> 27841704

HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Serena Bernacchi1, Ekram W Abd El-Wahab1, Noé Dubois1, Marcel Hijnen2,3, Redmond P Smyth1, Johnson Mak2,3,4,5, Roland Marquet1, Jean-Christophe Paillart1.   

Abstract

The HIV-1 Pr55Gag precursor specifically selects genomic RNA (gRNA) from a large variety of cellular and spliced viral RNAs (svRNAs), however the molecular mechanisms of this selective recognition remains poorly understood. To gain better understanding of this process, we analyzed the interactions between Pr55Gag and a large panel of viral RNA (vRNA) fragments encompassing the main packaging signal (Psi) and its flanking regions by fluorescence spectroscopy. We showed that the gRNA harbors a high affinity binding site which is absent from svRNA species, suggesting that this site might be crucial for selecting the HIV-1 genome. Our stoichiometry analysis of protein/RNA complexes revealed that few copies of Pr55Gag specifically associate with the 5' region of the gRNA. Besides, we found that gRNA dimerization significantly impacts Pr55Gag binding, and we confirmed that the internal loop of stem-loop 1 (SL1) in Psi is crucial for specific interaction with Pr55Gag. Our analysis of gRNA fragments of different length supports the existence of a long-range tertiary interaction involving sequences upstream and downstream of the Psi region. This long-range interaction might promote optimal exposure of SL1 for efficient Pr55Gag recognition. Altogether, our results shed light on the molecular mechanisms allowing the specific selection of gRNA by Pr55Gag among a variety of svRNAs, all harboring SL1 in their first common exon.

Entities:  

Keywords:  Fluorescence spectroscopy; HIV-1; Pr55Gag; genomic RNA selection; high affinity binding site; protein-RNA interaction; stoichiometry

Mesh:

Substances:

Year:  2016        PMID: 27841704      PMCID: PMC5270550          DOI: 10.1080/15476286.2016.1256533

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  111 in total

1.  NMR structure of stem-loop SL2 of the HIV-1 psi RNA packaging signal reveals a novel A-U-A base-triple platform.

Authors:  G K Amarasinghe; R N De Guzman; R B Turner; M F Summers
Journal:  J Mol Biol       Date:  2000-05-26       Impact factor: 5.469

2.  Expression and purification of soluble recombinant full length HIV-1 Pr55(Gag) protein in Escherichia coli.

Authors:  William J McKinstry; Marcel Hijnen; Hanumant S Tanwar; Lindsay G Sparrow; Sureshbabu Nagarajan; Son T Pham; Johnson Mak
Journal:  Protein Expr Purif       Date:  2014-05-06       Impact factor: 1.650

3.  Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.

Authors:  Y X Feng; T D Copeland; L E Henderson; R J Gorelick; W J Bosche; J G Levin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  A non-cleavable hexahistidine affinity tag at the carboxyl-terminus of the HIV-1 Pr55Gag polyprotein alters nucleic acid binding properties.

Authors:  Maria C Bewley; Lisa Reinhart; Matthew S Stake; Shorena Nadaraia-Hoke; Leslie J Parent; John M Flanagan
Journal:  Protein Expr Purif       Date:  2016-10-06       Impact factor: 1.650

6.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

7.  In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.

Authors:  S Campbell; A Rein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.

Authors:  A Lever; H Gottlinger; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

9.  HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms.

Authors:  Laurent Houzet; Jean Christophe Paillart; Fatima Smagulova; Stephan Maurel; Zakia Morichaud; Roland Marquet; Marylène Mougel
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

10.  Live-cell observation of cytosolic HIV-1 assembly onset reveals RNA-interacting Gag oligomers.

Authors:  Jelle Hendrix; Viola Baumgärtel; Waldemar Schrimpf; Sergey Ivanchenko; Michelle A Digman; Enrico Gratton; Hans-Georg Kräusslich; Barbara Müller; Don C Lamb
Journal:  J Cell Biol       Date:  2015-08-17       Impact factor: 10.539

View more
  30 in total

1.  The C-terminal p6 domain of the HIV-1 Pr55Gag precursor is required for specific binding to the genomic RNA.

Authors:  Noé Dubois; Keith K Khoo; Shannon Ghossein; Tanja Seissler; Philippe Wolff; William J McKinstry; Johnson Mak; Jean-Christophe Paillart; Roland Marquet; Serena Bernacchi
Journal:  RNA Biol       Date:  2018-08-04       Impact factor: 4.652

2.  HIV-1 Gag protein with or without p6 specifically dimerizes on the viral RNA packaging signal.

Authors:  Samantha Sarni; Banhi Biswas; Shuohui Liu; Erik D Olson; Jonathan P Kitzrow; Alan Rein; Vicki H Wysocki; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

3.  Zinc Fingers in HIV-1 Gag Precursor Are Not Equivalent for gRNA Recruitment at the Plasma Membrane.

Authors:  Emmanuel Boutant; Jeremy Bonzi; Halina Anton; Maaz Bin Nasim; Raphael Cathagne; Eléonore Réal; Denis Dujardin; Philippe Carl; Pascal Didier; Jean-Christophe Paillart; Roland Marquet; Yves Mély; Hugues de Rocquigny; Serena Bernacchi
Journal:  Biophys J       Date:  2020-06-12       Impact factor: 4.033

4.  A purine loop and the primer binding site are critical for the selective encapsidation of mouse mammary tumor virus genomic RNA by Pr77Gag.

Authors:  Akhil Chameettachal; Valérie Vivet-Boudou; Fathima Nuzra Nagoor Pitchai; Vineeta N Pillai; Lizna Mohamed Ali; Anjana Krishnan; Serena Bernacchi; Farah Mustafa; Roland Marquet; Tahir A Rizvi
Journal:  Nucleic Acids Res       Date:  2021-05-07       Impact factor: 16.971

5.  The role of packaging signals in virus assembly and the interplay between the nucleation and elongation rates.

Authors:  Mauricio Comas-Garcia
Journal:  Biophys J       Date:  2022-06-03       Impact factor: 3.699

Review 6.  Retroviral Gag protein-RNA interactions: Implications for specific genomic RNA packaging and virion assembly.

Authors:  Erik D Olson; Karin Musier-Forsyth
Journal:  Semin Cell Dev Biol       Date:  2018-04-01       Impact factor: 7.727

7.  Specific Guanosines in the HIV-2 Leader RNA are Essential for Efficient Viral Genome Packaging.

Authors:  Chijioke N Umunnakwe; Alice Duchon; Olga A Nikolaitchik; Sheikh Abdul Rahman; Yang Liu; Jianbo Chen; Sheldon Tai; Vinay K Pathak; Wei-Shau Hu
Journal:  J Mol Biol       Date:  2020-11-19       Impact factor: 6.151

8.  Selective packaging of HIV-1 RNA genome is guided by the stability of 5' untranslated region polyA stem.

Authors:  Olga A Nikolaitchik; Shuohui Liu; Jonathan P Kitzrow; Yang Liu; Jonathan M O Rawson; Saurabh Shakya; Zetao Cheng; Vinay K Pathak; Wei-Shau Hu; Karin Musier-Forsyth
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

Review 9.  The Life-Cycle of the HIV-1 Gag-RNA Complex.

Authors:  Elodie Mailler; Serena Bernacchi; Roland Marquet; Jean-Christophe Paillart; Valérie Vivet-Boudou; Redmond P Smyth
Journal:  Viruses       Date:  2016-09-10       Impact factor: 5.048

10.  Dissection of specific binding of HIV-1 Gag to the 'packaging signal' in viral RNA.

Authors:  Mauricio Comas-Garcia; Siddhartha Ak Datta; Laura Baker; Rajat Varma; Prabhakar R Gudla; Alan Rein
Journal:  Elife       Date:  2017-07-20       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.